Published in J Antimicrob Chemother on September 15, 2011
Off-label medicine use in children and adolescents: results of a population-based study in Germany. BMC Public Health (2013) 0.95
Optimizing Antibiotic Stewardship in Nursing Homes: A Narrative Review and Recommendations for Improvement. Drugs Aging (2015) 0.94
Improving antibiotic prescribing for children in the resource-poor setting. Br J Clin Pharmacol (2015) 0.83
Impact of a United Kingdom-wide campaign to tackle antimicrobial resistance on self-reported knowledge and behaviour change. BMC Public Health (2016) 0.81
Antimicrobial Stewardship and Urinary Tract Infections. Antibiotics (Basel) (2014) 0.80
Perceptions and knowledge regarding antimicrobial stewardship among clinicians in Jeddah, Saudi Arabia. Saudi Med J (2015) 0.79
Biomedical evaluation of a novel nitrogen oxides releasing wound dressing. J Mater Sci Mater Med (2012) 0.77
Interventions to improve antimicrobial prescribing of doctors in training: the IMPACT (IMProving Antimicrobial presCribing of doctors in Training) realist review. BMJ Open (2015) 0.77
Off-label drug use in hospitalized children: a prospective observational study at Gondar University Referral Hospital, Northwestern Ethiopia. Pharmacol Res Perspect (2017) 0.75
Antibiotic Stewardship Initiatives as Part of the UK 5-Year Antimicrobial Resistance Strategy. Antibiotics (Basel) (2015) 0.75
The impact of an antimicrobial stewardship programme on the use of antimicrobials and the evolution of drug resistance. Eur J Clin Microbiol Infect Dis (2014) 0.75
Primary care of children: the unique role of GPs. Br J Gen Pract (2012) 2.76
Morbidity, mortality, and response to treatment by children in the United Kingdom and Ireland with perinatally acquired HIV infection during 1996-2006: planning for teenage and adult care. Clin Infect Dis (2007) 2.35
Increasing short-stay unplanned hospital admissions among children in England; time trends analysis '97-'06. PLoS One (2009) 2.24
Ciprofloxacin resistance in Neisseria gonorrhoeae in England and Wales in 2002. Lancet (2003) 2.21
PENTA 2009 guidelines for the use of antiretroviral therapy in paediatric HIV-1 infection. HIV Med (2009) 2.16
Decline of EMRSA-16 amongst methicillin-resistant Staphylococcus aureus causing bacteraemias in the UK between 2001 and 2007. J Antimicrob Chemother (2009) 2.05
Characterization of group B streptococci recovered from infants with invasive disease in England and Wales. Clin Infect Dis (2004) 1.91
Improving the quality of antibiotic prescribing in the NHS by developing a new Antimicrobial Stewardship Programme: Start Smart--Then Focus. J Antimicrob Chemother (2012) 1.86
The new UK antimicrobial resistance strategy and action plan. BMJ (2013) 1.86
A potential role for daptomycin in enterococcal infections: what is the evidence? J Antimicrob Chemother (2010) 1.77
Response to highly active antiretroviral therapy varies with age: the UK and Ireland Collaborative HIV Paediatric Study. AIDS (2004) 1.67
Outcome of Cushing's disease following transsphenoidal surgery in a single center over 20 years. J Clin Endocrinol Metab (2012) 1.61
CD4 cell count and the risk of AIDS or death in HIV-Infected adults on combination antiretroviral therapy with a suppressed viral load: a longitudinal cohort study from COHERE. PLoS Med (2012) 1.54
Linezolid-resistant enterococci: report of the first isolates in the United Kingdom. J Antimicrob Chemother (2002) 1.51
Trends in fluoroquinolone (ciprofloxacin) resistance in enterobacteriaceae from bacteremias, England and Wales, 1990-1999. Emerg Infect Dis (2002) 1.51
A new UK strain of epidemic methicillin-resistant Staphylococcus aureus (EMRSA-17) resistant to multiple antibiotics. J Antimicrob Chemother (2002) 1.35
Prevalence and mechanisms of cephalosporin resistance in Enterobacteriaceae in London and South-East England. J Antimicrob Chemother (2006) 1.35
Systematic analysis of funding awarded for antimicrobial resistance research to institutions in the UK, 1997-2010. J Antimicrob Chemother (2013) 1.34
Outcomes for human immunodeficiency virus-1-infected infants in the United kingdom and Republic of Ireland in the era of effective antiretroviral therapy. Pediatr Infect Dis J (2006) 1.33
Editorial: assessing the antimicrobial susceptibility of bacteria obtained from animals. J Antimicrob Chemother (2010) 1.28
Young people in the United Kingdom and Ireland with perinatally acquired HIV: the pediatric legacy for adult services. AIDS Patient Care STDS (2009) 1.23
Effect of antibiotics for otitis media on mastoiditis in children: a retrospective cohort study using the United kingdom general practice research database. Pediatrics (2009) 1.22
Declining cephalosporin and fluoroquinolone non-susceptibility among bloodstream Enterobacteriaceae from the UK: links to prescribing change? J Antimicrob Chemother (2013) 1.19
Antibiotic therapy for pediatric community-acquired pneumonia: do we know when, what and for how long to treat? Pediatr Infect Dis J (2012) 1.19
High neonatal concentrations of raltegravir following transplacental transfer in HIV-1 positive pregnant women. AIDS (2010) 1.09
Effect of tenofovir disoproxil fumarate on risk of renal abnormality in HIV-1-infected children on antiretroviral therapy: a nested case-control study. AIDS (2010) 1.09
Incidence, etiology, and outcome of bacterial meningitis in infants aged <90 days in the United kingdom and Republic of Ireland: prospective, enhanced, national population-based surveillance. Clin Infect Dis (2014) 1.08
Assessing the antimicrobial susceptibility of bacteria obtained from animals. Vet Microbiol (2009) 1.06
Use of antibacterial agents in the neonate: 50 years of experience with vancomycin administration. Semin Fetal Neonatal Med (2012) 1.01
Off-label antibiotic use in children in three European countries. Eur J Clin Pharmacol (2010) 1.00
The antibiotic resistance and prescribing in European Children project: a neonatal and pediatric antimicrobial web-based point prevalence survey in 73 hospitals worldwide. Pediatr Infect Dis J (2013) 0.99
Nevirapine use in HIV-1-infected children. AIDS (2003) 0.99
Oral penicillin prescribing for children in the UK: a comparison with BNF for Children age-band recommendations. Br J Gen Pract (2014) 0.96
Improving antibiotic prescribing in neonatal units: time to act. Arch Dis Child Fetal Neonatal Ed (2010) 0.95
Use of stored dried blood spots for retrospective diagnosis of congenital CMV. J Med Virol (2009) 0.94
Haplotype mapping of the bronchiolitis susceptibility locus near IL8. Hum Genet (2003) 0.94
Risk-benefit analysis of restricting antimicrobial prescribing in children: what do we really know? Curr Opin Infect Dis (2010) 0.93
Preventing severe respiratory syncytial virus disease: passive, active immunisation and new antivirals. Arch Dis Child (2014) 0.93
Neonatal and pediatric antimicrobial stewardship programs in Europe-defining the research agenda. Pediatr Infect Dis J (2013) 0.93
Genetic variation at the IL10 gene locus is associated with severity of respiratory syncytial virus bronchiolitis. J Infect Dis (2005) 0.91
Antibiotic prescribing for upper respiratory infections: European primary paediatricians' knowledge, attitudes and practice. Acta Paediatr (2012) 0.91
Significantly increasing hospital admissions for acute throat infections among children in England: is this related to tonsillectomy rates? Arch Dis Child (2012) 0.91
Antibiotic dosing in children in Europe: can we grade the evidence from pharmacokinetic/pharmacodynamic studies - and when is enough data enough? Curr Opin Infect Dis (2012) 0.90
Acute haematogenous osteomyelitis in children: is there any evidence for how long we should treat? Curr Opin Infect Dis (2008) 0.89
Activity of dalbavancin against staphylococci and streptococci, assessed by BSAC and NCCLS agar dilution methods. J Antimicrob Chemother (2004) 0.89
Variants of the chemokine receptor CCR5 are associated with severe bronchiolitis caused by respiratory syncytial virus. J Infect Dis (2003) 0.89
Steroids fail to down-regulate respiratory syncytial virus-induced IL-8 secretion in infants. Pediatr Res (2002) 0.89
The changing aetiology of paediatric bacteraemia in England and Wales, 1998-2007. J Med Microbiol (2009) 0.89
Changes in the classification and management of skin and soft tissue infections. J Antimicrob Chemother (2010) 0.88
Comparing neonatal and paediatric antibiotic prescribing between hospitals: a new algorithm to help international benchmarking. J Antimicrob Chemother (2012) 0.87
Prevention of respiratory syncytial virus infection in infants. BMJ (2004) 0.86
Evaluating the feasibility of integrating salivary testing for congenital CMV into the Newborn Hearing Screening Programme in the UK. Eur J Pediatr (2015) 0.86
Antibiotic Resistance Prevalence in Routine Bloodstream Isolates from Children's Hospitals Varies Substantially from Adult Surveillance Data in Europe. Pediatr Infect Dis J (2015) 0.86
The epidemiology of neonatal and pediatric candidemia in England and Wales, 2000-2009. Pediatr Infect Dis J (2013) 0.85
Managing and preventing outbreaks of Gram-negative infections in UK neonatal units. Arch Dis Child Fetal Neonatal Ed (2013) 0.85
Prevalence of nasopharyngeal carriage of pneumococcus in preschool children attending day care in London. Arch Dis Child (2007) 0.85
Continuing impact of infectious diseases on childhood deaths in England and Wales, 2003-2005. Pediatr Infect Dis J (2010) 0.85
Feasibility and acceptability of targeted screening for congenital CMV-related hearing loss. Arch Dis Child Fetal Neonatal Ed (2014) 0.85
National guidelines for decolonization of methicillin-resistant Staphylococcus aureus carriers: the implications of recent experience in the Netherlands. J Antimicrob Chemother (2011) 0.84
The European Union Antibiotic Awareness Day: the paediatric perspective. Arch Dis Child (2008) 0.84
Current management of late onset neonatal bacterial sepsis in five European countries. Eur J Pediatr (2014) 0.84
Clinical trials in neonatal sepsis. J Antimicrob Chemother (2013) 0.83
Aminoglycoside toxicity in neonates: something to worry about? Expert Rev Anti Infect Ther (2014) 0.83
Epidemiology and clinical outcomes of multidrug-resistant, gram-negative bloodstream infections in a European tertiary pediatric hospital during a 12-month period. Pediatr Infect Dis J (2014) 0.83
Ganciclovir treatment in children: evidence of subtherapeutic levels. Int J Antimicrob Agents (2011) 0.83
Improving antibiotic prescribing for children in the resource-poor setting. Br J Clin Pharmacol (2015) 0.83
Invasive bacterial and fungal infections in paediatric patients with cancer: incidence, risk factors, aetiology and outcomes in a UK regional cohort 2009-2011. Pediatr Blood Cancer (2014) 0.83
Isolation and antimicrobial sensitivities of Kluyvera spp. from humans in England, Wales and Northern Ireland, 2005-2006. Int J Antimicrob Agents (2007) 0.82
Absence of Cushingoid phenotype in a patient with Cushing's disease due to defective cortisone to cortisol conversion. J Clin Endocrinol Metab (2002) 0.82
RSV-infected airway epithelial cells cause biphasic up-regulation of CCR1 expression on human monocytes. J Leukoc Biol (2007) 0.82
Chemokines and their receptors in respiratory disease: a therapeutic target for respiratory syncytial virus infection. Expert Rev Anti Infect Ther (2007) 0.82
New antibiotics for paediatric use: a review of a decade of regulatory trials submitted to the European Medicines Agency from 2000--why aren't we doing better? Int J Antimicrob Agents (2013) 0.82
Increasing skin infections and Staphylococcus aureus complications in children, England, 1997-2006. Emerg Infect Dis (2010) 0.82
The European Antibiotic Awareness Day. J Antimicrob Chemother (2008) 0.81
Reduction in erythromycin resistance in invasive pneumococci from young children in England and Wales. J Antimicrob Chemother (2009) 0.81
Clinical and microbiologic features guiding treatment recommendations for brain abscesses in children. Pediatr Infect Dis J (2013) 0.81
Neonatal sepsis--many blood samples, few positive cultures: implications for improving antibiotic prescribing. Arch Dis Child Fetal Neonatal Ed (2012) 0.81
The emergence of Stenotrophomonas maltophilia. BMJ (2008) 0.80
Neonatal adrenal abscess revisited: the importance of raised inflammatory markers. Ann Trop Paediatr (2005) 0.80
Measuring antibiotic prescribing in hospitalised children in resource-poor countries: a systematic review. J Paediatr Child Health (2011) 0.80
Low in vitro selection frequencies of enterococcal and staphylococcal mutants resistant to the oxazolidinone AZD2563. Int J Antimicrob Agents (2004) 0.80
How to use vancomycin optimally in neonates: remaining questions. Expert Rev Clin Pharmacol (2015) 0.79
Advances in the antiviral therapy of herpes virus infection in children. Expert Rev Anti Infect Ther (2006) 0.79
The contribution of infections to neonatal deaths in England and Wales. Pediatr Infect Dis J (2011) 0.79
Chemokine-receptor upregulation and disease severity in respiratory syncytial virus infection. Clin Immunol (2008) 0.79
Diagnosis and treatment of aspergillosis in children. Expert Rev Anti Infect Ther (2009) 0.79
Trends in penicillin and macrolide resistance among pneumococci in the UK and the Republic of Ireland in relation to antibiotic sales to pharmacies and dispensing doctors. Int J Antimicrob Agents (2006) 0.79
Use of serial maternal urine cytomegalovirus PCR to detect primary CMV infection in seronegative pregnant women. J Virol Methods (2004) 0.78
Rifampicin pharmacokinetics in extreme prematurity to treat congenital tuberculosis. BMJ Case Rep (2013) 0.78
Amphotericin B in neonates: deoxycholate or lipid formulation as first-line therapy - is there a 'right' choice? Curr Opin Infect Dis (2011) 0.78
Interventions in health-care-associated infection: researchers urged to CONSORT with ORION. Lancet Infect Dis (2007) 0.78
What errors can be identified by Pharmacy-led medicines reconciliation? A prospective study. Acute Med (2011) 0.77